SCHEMBL26186181

SCHEMBL26186181

CCOC(=O)c1ccc(OC(=O)C2CCC(C)CC2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 2/20 0.53
▸ ELANE P08246 2/20 0.51
▸ HTT P42858 2/20 0.49
▸ KMT2A Q03164 2/20 0.49
▸ SMN1; SMN2 Q16637 1/20 0.49
▸ TDP1 Q9NUW8 1/20 0.49
▸ CA12 O43570 1/20 0.47
▸ CA1 P00915 1/20 0.47
▸ CA2 P00918 1/20 0.47
▸ ESR1 P03372 1/20 0.47
▸ CA7 P43166 1/20 0.47
▸ CA9 Q16790 1/20 0.47
▸ ESR2 Q92731 1/20 0.47
▸ CA14 Q9ULX7 1/20 0.47
▸ PRSS1 P07477 1/20 0.47
▸ ACR P10323 1/20 0.47
▸ STS P08842 1/20 0.47
▸ CYP1A2 P05177 2/20 0.46
▸ LMNA P02545 1/20 0.46
▸ CYP3A4 P08684 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4544912 0.94 RAB9A (0.58) RAB9AELANEHTTKMT2ASMN1; SMN2
SCHEMBL14510047 0.90 RAB9A (0.55) RAB9AELANEHTTKMT2ASMN1; SMN2
SCHEMBL8929996 0.84 ELANE (0.52) RAB9AELANEHTTKMT2ASMN1; SMN2
SCHEMBL8930089 0.84 ELANE (0.52) RAB9AELANEHTTKMT2ASMN1; SMN2
SCHEMBL13135283 0.84 ELANE (0.52) RAB9AELANEHTTKMT2ASMN1; SMN2
SCHEMBL14609923 0.84 RAB9A (0.52) RAB9AELANEHTTKMT2ASMN1; SMN2
SCHEMBL23511046 0.84 ELANE (0.55) RAB9AELANEHTTKMT2ASMN1; SMN2
SCHEMBL13135270 0.83 KMT2A (0.68) RAB9AELANEHTTKMT2ASMN1; SMN2
SCHEMBL13135348 0.83 KMT2A (0.68) RAB9AELANEHTTKMT2ASMN1; SMN2
SCHEMBL22102172 0.83 KMT2A (0.50) ELANEHTTKMT2ASMN1; SMN2TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240067879-A1 Liquid-crystal medium MERCK PATENT GMBH (DE) 2024-02-29 — — US disclosed
US-20240072425-A1 AROMATIC ISOTHIOCYANATES MERCK PATENT GMBH (DE) 2024-02-29 — — US disclosed
US-11802243-B2 Liquid-crystal medium MERCK PATENT GMBH (DE) 2023-10-31 — — US disclosed
US-20230295510-A1 LIQUID CRYSTAL MEDIUM MERCK PATENT GMBH (DE) 2023-09-21 — — US disclosed
US-20230295511-A1 LIQUID CRYSTAL MEDIUM MERCK PATENT GMBH (DE) 2023-09-21 — — US disclosed
US-11739265-B2 Aromatic isothiocyanates MERCK PATENT GMBH (DE) 2023-08-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240072425-A1 AROMATIC ISOTHIOCYANATES TRPA1, TRPC1, CRY1 RAB9A 2624/4885ELANE 3711/4885HTT 857/4885
US-11739265-B2 Aromatic isothiocyanates TRPA1, CRY1, FOXM1 RAB9A 2557/4885ELANE 3358/4885HTT 610/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback